News & Perspective

May 09, 2018

May 09, 2018

News Scan for May 09, 2018

More romaine E coli cases
Predicting pandemic severity
Lassa fever cases
HPV vaccine meta-analysis

Apr 30, 2010

Apr 30, 2010

H1N1 LESSONS LEARNED Vaccination campaign weathered rough road, paid dividends

This is the third in a series of reports marking the first anniversary of novel H1N1 pandemic influenza. The first and second articles appeared on Apr 23 and Apr 26.

Feb 24, 2010

Feb 24, 2010

Emergency departments see rise in flu-like illness

(CIDRAP News) – Some of the nation's emergency departments are noting increases in flu-like illness cases that appear to be pandemic H1N1, and colleges are reporting the first increase in flu-like illness since the end of November, but it's not clear if these are early signs of a third pandemic flu wave.

Oct 21, 2009

Oct 21, 2009

Minnesota flu line will speed antivirals to at-risk patients

(CIDRAP News) – In a move designed to lighten the burden on emergency departments and clinics, Minnesota officials today unveiled a flu triage line staffed by nurses who can discuss symptoms with sick patients, suggest treatment steps, and prescribe an antiviral drug if the caller is in a high-risk category.

Sep 22, 2009

Sep 22, 2009

Business conference airs challenges of H1N1 vaccine campaign

(CIDRAP News) – With the second wave of the H1N1 influenza virus now hitting, much of the response toe the pandemic is focused on the development and distribution of an effective vaccine, a project that poses many challenges and uncertainties.

May 08, 2009

May 08, 2009

Demand, flu patterns lead states to reduce testing

(CIDRAP News) – As state public health laboratories tackle their novel H1N1 influenza (swine flu) testing backlogs, the Centers for Disease Control and Prevention (CDC) said yesterday it expects to see rising case numbers across the nation along with cutbacks in the number of samples tested by states.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»